ONEMEDNET CORPORATION Diluted Shares Outstanding (Weighted Average)
ONEMEDNET CORPORATION (ONMD) reported Diluted Shares Outstanding (Weighted Average) of 58.02 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-14
- ONEMEDNET CORPORATION weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 58.02M shares, a 51.07% increase year-over-year.
- ONEMEDNET CORPORATION weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 55.32M shares, a 62.20% increase year-over-year.
- ONEMEDNET CORPORATION weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 49.27M shares, a 48.02% increase year-over-year.
- ONEMEDNET CORPORATION weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 52.62M shares, a 79.80% increase year-over-year.
- ONEMEDNET CORPORATION weighted average number of shares outstanding, diluted for fiscal 2023 was 7.27M shares, a 82.97% increase from fiscal 2022.
- ONEMEDNET CORPORATION weighted average number of shares outstanding, diluted for fiscal 2022 was 3.97M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 58.02M shares 10-Q · filed 2026-08-14 | 56.79M shares 10-Q · filed 2026-08-14 | 54.20M shares derived: average of 3 quarters · filed 2026-08-14 | 53.81M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | 55.32M shares S-1/A · filed 2026-07-08 | 52.29M shares derived: average of 2 quarters · filed 2026-07-08 | 52.40M shares derived: average of 3 quarters · filed 2026-07-08 | 48.90M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | 49.27M shares derived: S-1/A 12 month − 10-Q 9 month · filed 2026-07-08 | 50.94M shares derived: average of 2 quarters · filed 2026-07-08 | 46.76M shares derived: average of 3 quarters · filed 2026-08-14 | 44.55M shares S-1/A · filed 2026-07-08 | ||||
| 2025-09-30 | 52.62M shares 10-Q · filed 2025-11-14 | 45.51M shares derived: average of 2 quarters · filed 2026-08-14 | 42.97M shares 10-Q · filed 2025-11-14 | 39.60M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | 38.41M shares 10-Q · filed 2026-08-14 | 37.13M shares 10-Q · filed 2026-08-14 | 35.26M shares derived: average of 3 quarters · filed 2026-08-14 | 33.76M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | 34.10M shares S-1/A · filed 2026-07-08 | 33.69M shares derived: average of 2 quarters · filed 2026-07-08 | 32.22M shares derived: average of 3 quarters · filed 2026-07-08 | 30.46M shares derived: average of 4 quarters · filed 2026-07-08 | ||||
| 2024-12-31 | 33.28M shares derived: S-1/A 12 month − 10-Q 9 month · filed 2026-07-08 | 31.27M shares derived: average of 2 quarters · filed 2026-07-08 | 29.24M shares derived: average of 3 quarters · filed 2026-07-08 | 28.08M shares S-1/A · filed 2026-07-08 | ||||
| 2024-09-30 | 29.27M shares 10-Q · filed 2025-11-14 | 27.88M shares 10-Q · filed 2024-12-17 | 27.22M shares derived: average of 2 quarters · filed 2025-11-14 | 26.34M shares 10-Q · filed 2025-11-14 | 25.05M shares 10-Q · filed 2024-12-17 | 24.01M shares derived: average of 4 quarters · filed 2025-11-14 | ||
| 2024-06-30 | 25.18M shares 10-Q · filed 2025-08-13 | 23.94M shares 10-Q · filed 2024-12-11 | 24.96M shares 10-Q · filed 2025-08-13 | 23.72M shares 10-Q · filed 2024-12-11 | 22.26M shares derived: average of 3 quarters · filed 2025-08-13 | 17.76M shares derived: average of 4 quarters · filed 2025-08-13 | ||
| 2024-03-31 | 24.92M shares 10-Q · filed 2025-05-14 | 23.68M shares 10-Q · filed 2024-12-05 | 20.79M shares derived: average of 2 quarters · filed 2025-05-14 | 15.29M shares derived: average of 3 quarters · filed 2025-05-14 | 12.48M shares derived: average of 4 quarters · filed 2025-05-14 | |||
| 2023-12-31 | 16.66M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | 10.47M shares derived: average of 2 quarters · filed 2025-04-15 | 8.33M shares derived: average of 3 quarters · filed 2025-04-15 | 7.27M shares 10-K · filed 2025-04-15 | 23.57M shares 10-K · filed 2024-04-09 | |||
| 2023-09-30 | 4.28M shares 10-Q · filed 2024-12-17 | 4.83M shares 8-K/A · filed 2024-11-22 | 4.16M shares derived: average of 2 quarters · filed 2024-12-17 | 4.14M shares 10-Q · filed 2024-12-17 | 12.66M shares 10-Q · filed 2023-11-20 | 3.71M shares derived: average of 4 quarters · filed 2024-12-17 | ||
| 2023-06-30 | 4.03M shares 10-Q · filed 2024-12-11 | 4.03M shares 10-Q · filed 2024-12-11 | 3.53M shares derived: average of 3 quarters · filed 2024-12-11 | 3.73M shares derived: average of 4 quarters · filed 2024-12-11 | ||||
| 2023-03-31 | 4.03M shares 10-Q · filed 2024-12-05 | 3.27M shares derived: average of 2 quarters · filed 2024-12-05 | 3.63M shares derived: average of 3 quarters · filed 2024-12-05 | |||||
| 2022-12-31 | 2.51M shares derived: 10-K/A 12 month − 8-K/A 9 month · filed 2024-11-05 | 3.43M shares derived: average of 2 quarters · filed 2024-11-22 | 3.97M shares 10-K/A · filed 2024-11-05 | |||||
| 2022-09-30 | 4.34M shares 8-K/A · filed 2024-11-22 | 4.46M shares 8-K/A · filed 2024-11-22 | 8.57M shares 10-Q · filed 2023-11-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |